GTR 115525153

Tenders Are Invited For Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-Called Open House Procedure.

ICB — International Competitive Bid Closes Dec 31, 2026 Western Europe
Tender Information
GTR Reference
115525153
Tendering Authority
Subscribe to view
Tender No
463909-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-Called Open House Procedure.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
31-12-2026
Work Detail
Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-Called Open House Procedure.. The Kaufmännische Krankenkasse - Kkh (Hereinafter Kkh) Pursues The Goal Of Concluding Discount Agreements With All Suitable Pharmaceutical Companies In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient (Atc) Mentioned Under Bt-21-Lot And, If Necessary, Restricting It To Certain Dosage Forms Within The Framework Of A So-Called Open-House Procedure. Subject To Uniform Contractual Conditions And A Uniform Access Procedure, All Suitable And Interested Pharmaceutical Companies Or Communities Of Pharmaceutical Companies Are Offered The Opportunity To Conclude Or Join A Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Above-Mentioned Active Ingredient. Interested Pharmaceutical Companies Can Request The Participation Documents And The Contract From The Contact Address Provided. The Prerequisite For Concluding A Contract Is That The Interested Pharmaceutical Company Submits The Requested Participation Documents, Completely Completed And Signed. A Contract Is Concluded With Each Pharmaceutical Company That Meets The Participation Requirements. There Is No Exclusivity. Joining Or Concluding A Contract Can Take Place At Any Time And Under The Same Conditions. Individual Contract Negotiations Will Not Be Carried Out. If The Kkh Carries Out A Tender For Exclusive Contracts For The Active Ingredients In The Form Of The Open Procedure During The Contract Term, The Contracts Concluded Within The Framework Of This Publication Will Be Terminated In Accordance With The Contractual Regulations.
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
b2c6cfb1-da26-441c-8b83-e2d613fe05b3.html
Attachments
Additional Details Available on Click
  • Tendering Authority
  • Publication Document (Tender Document / Tender Notice)
Disclaimer

We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.

Tell us about your Product / Services,

We will Find Tenders for you

TenderDetail
Loading tenders